MXPA01009174A - Antagonistas de endotelina novedosos derivados de piridazina. - Google Patents

Antagonistas de endotelina novedosos derivados de piridazina.

Info

Publication number
MXPA01009174A
MXPA01009174A MXPA01009174A MXPA01009174A MXPA01009174A MX PA01009174 A MXPA01009174 A MX PA01009174A MX PA01009174 A MXPA01009174 A MX PA01009174A MX PA01009174 A MXPA01009174 A MX PA01009174A MX PA01009174 A MXPA01009174 A MX PA01009174A
Authority
MX
Mexico
Prior art keywords
endothelin
endothelin antagonists
compounds
new pyridazine
pyridazine
Prior art date
Application number
MXPA01009174A
Other languages
English (en)
Inventor
John Schulz Darren
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA01009174A publication Critical patent/MXPA01009174A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

Compuestos de formula (I): (ver formula) tienen afinidad por receptores de endotelina, son selectivos por ETA sobre ETB, y son potencialmente utiles en el tratamiento de condiciones mediadas por endotelina.
MXPA01009174A 2000-09-20 2001-09-11 Antagonistas de endotelina novedosos derivados de piridazina. MXPA01009174A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0023074.8A GB0023074D0 (en) 2000-09-20 2000-09-20 Pyridazines

Publications (1)

Publication Number Publication Date
MXPA01009174A true MXPA01009174A (es) 2004-10-15

Family

ID=9899818

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01009174A MXPA01009174A (es) 2000-09-20 2001-09-11 Antagonistas de endotelina novedosos derivados de piridazina.

Country Status (12)

Country Link
EP (1) EP1191026B1 (es)
JP (1) JP3545735B2 (es)
AT (1) ATE267193T1 (es)
BR (1) BR0104141A (es)
CA (1) CA2357687C (es)
DE (1) DE60103342T2 (es)
DK (1) DK1191026T3 (es)
ES (1) ES2220677T3 (es)
GB (1) GB0023074D0 (es)
MX (1) MXPA01009174A (es)
PT (1) PT1191026E (es)
TR (1) TR200401185T4 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533693A (en) 2002-01-02 2007-02-23 Actelion Pharmaceuticals Ltd Alkansulfonamides as endothelin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096657B1 (de) * 1982-06-08 1989-04-05 Ciba-Geigy Ag 2-Phenyl-, 2-Naphthyl- und 2-Heterocyclylpyrimidine als Gegenmittel zum Schützen von Kulturpflanzen vor durch Herbizide verursachte phytotoxische Schäden
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
DE19537548A1 (de) * 1995-10-09 1997-04-10 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE69612874T2 (de) * 1995-12-20 2001-10-04 Yamanouchi Pharma Co Ltd Arylethensulfonamid-derivate und diese enthaltende medikamente

Also Published As

Publication number Publication date
DE60103342D1 (de) 2004-06-24
ATE267193T1 (de) 2004-06-15
DK1191026T3 (da) 2004-06-28
EP1191026B1 (en) 2004-05-19
TR200401185T4 (tr) 2004-06-21
EP1191026A1 (en) 2002-03-27
JP2002128780A (ja) 2002-05-09
PT1191026E (pt) 2004-10-29
DE60103342T2 (de) 2004-09-23
CA2357687C (en) 2006-03-14
GB0023074D0 (en) 2000-11-01
CA2357687A1 (en) 2002-03-20
BR0104141A (pt) 2002-07-09
JP3545735B2 (ja) 2004-07-21
ES2220677T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
DE60130799D1 (en) Synthese von 4-aminothalidomid enantiomeren
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
BG66103B1 (bg) Кондензирани пиролокарбазоли
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
JO2371B1 (en) 4-phenyl-pyridine derivatives
DE69728585D1 (de) Mittel gegen Juckreiz
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DE602004026053D1 (es)
TW200510416A (en) P38 inhibitors and methods of use thereof
DE60043120D1 (de) Polyhydroxystilbene und -stilbenoxide als antipsoriasismittel und proteinkinasehemmer
IS6658A (is) Ný efnasambönd
TR200200068T2 (tr) Nematisital triflüorobütenler
YU7797A (sh) Kombinovana terapija za osteoporozu
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
PT1353689E (pt) Composicoes imunizantes e metodos de utilizacao
HK1046912A1 (en) Substituted sapogenins and their use
GB0111186D0 (en) Novel compounds
YU13301A (sh) Muskarinski agonisti i antagonisti
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
TR200200278T2 (tr) Kalsilitik bileşimler
BRPI0409958A (pt) quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso
EP0916670A3 (en) Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists
MXPA01009174A (es) Antagonistas de endotelina novedosos derivados de piridazina.

Legal Events

Date Code Title Description
FG Grant or registration